10 likes | 148 Views
1 st Workgroup and 2 nd Management Committee meeting 16th – 17th March 2009 in Antwerp, Belgium. Conclusions - WG1 session 16 participants from 10 different countries with contributions on GEP in AML/MDS miRNA profiling in AML Potential collaborations within WG1: CBF
E N D
1st Workgroup and 2nd Management Committee meeting 16th – 17th March 2009 in Antwerp, Belgium • Conclusions - WG1 session • 16 participants from 10 different countries with contributions on • GEP in AML/MDS • miRNA profiling in AML • Potential collaborations within WG1: • CBF • CN-AML with CEBPAmut • Comparison of leukemia subgroups with “normal hematopoietic cells” • MDS • Potential collaborations other WGs: • “integrated analysis of different platforms” • devolop novel systems biology approaches • functional screens needed COST Action BM0801